p16 proteins from melanoma-prone families are deficient in binding to Cdk4

A Reymond1, R Brent

  • 1Department of Molecular Biology, Massachusetts General Hospital, Boston 02114, USA.

Oncogene
|September 21, 1995
PubMed

Insights

The tumor suppressor p16INK4 inhibits cell proliferation. Most p16 variants impair interaction with key cell cycle regulators (Cdks), increasing cancer risk, especially in familial melanoma cases.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • The p16INK4 protein acts as a tumor suppressor by inhibiting cell proliferation.
  • Mutations in the p16 gene are frequently observed in glioblastomas, pancreatic adenocarcinomas, and melanoma-prone families.
  • The functional impact of many p16 allelic variants has remained largely undetermined.

Purpose of the Study:

  • To investigate the interaction between seven p16 allelic variants found in melanoma-prone pedigrees and Cyclin-dependent kinases (Cdks).
  • To determine if impaired Cdk interaction by p16 variants correlates with cancer predisposition.

Main Methods:

  • Interaction mating assays were employed to assess protein-protein interactions.
  • Coprecipitation techniques were utilized to measure the binding affinity between p16 variants and Cdks.
  • Analysis included seven p16 allelic variants detected in individuals with a history of melanoma.

Main Results:

  • Most tested p16 allelic variants demonstrated reduced interaction with Cdk4 and Cdk6.
  • One variant, previously considered a common polymorphism, showed defective Cdk interaction.
  • A variant weakly associated with familial cancer exhibited only a minor decrease in Cdk binding affinity.

Conclusions:

  • p16INK4 allelic variants that exhibit decreased binding to Cdks are associated with an increased risk of cancer.
  • Assessing the binding affinity of p16 mutants to partner proteins can identify functionally significant variants.
  • This approach may reveal functionally important p16 variants missed by traditional genetic studies.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...